Status:
COMPLETED
Feasibility and Accuracy of a Wireless Vital Sign Monitor for Observation of Adult Patients in Uganda
Lead Sponsor:
Neopenda, PBC
Collaborating Sponsors:
Makerere University
Conditions:
Critical Illness
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This feasibility study will demonstrate the safety and accuracy of the Neopenda's wireless vital signs monitor, neoGuard, on 30 adult patients in a Ugandan clinical setting. The technology will be tes...
Detailed Description
Continuous vital sign monitoring is a basic tenet of specialized care in the developed world that is vastly underutilized in the intensive care units of most low-and-middle income countries. Despite t...
Eligibility Criteria
Inclusion
- Aged 18+ years (legal adult)
- Admitted for suspected or confirmed respiratory illness (excluding COVID-19)
- Stable clinical status (as determined by key physiological parameters pulse rate = 60-100 beats per minute, respiratory rate = 12-18 breaths per minute, oxygen saturation = 90 100% and temperature 36.5°C - 37.5° C)
- Willing and able to provide consent to receive vital sign monitoring
Exclusion
- Aged \<18 years
- Unstable clinical status as determined by physiological parameters (pulse rate \<60 bpm, or \>100bpm, respiratory rate \<12 brpm or \>18bpm, oxygen saturation \<90%, temperature \<36.5°C or \>37.5°C)
Key Trial Info
Start Date :
February 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 28 2021
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04761432
Start Date
February 15 2021
End Date
May 28 2021
Last Update
March 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jinja Regional Referral Hospital
Jinja, Uganda